These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34981044)

  • 1. The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters.
    Diamond M; Halfmann P; Maemura T; Iwatsuki-Horimoto K; Iida S; Kiso M; Scheaffer S; Darling T; Joshi A; Loeber S; Foster S; Ying B; Whitener B; Floyd K; Ujie M; Nakajima N; Ito M; Wright R; Uraki R; Li R; Sakai Y; Liu Y; Larson D; Osorio J; Hernandez-Ortiz J; Čiuoderis K; Florek K; Patel M; Bateman A; Odle A; Wong LY; Wang Z; Edara VV; Chong Z; Thackray L; Ueki H; Yamayoshi S; Imai M; Perlman S; Webby R; Seder R; Suthar M; Garcia-Sastre A; Schotsaert M; Suzuki T; Boon A; Kawaoka Y; Douek D; Moliva J; Sullivan N; Gagne M; Ransier A; Case J; Jeevan T; Franks J; Fabrizio T; DeBeauchamp J; Kercher L; Seiler P; Singh G; Warang P; Gonzalez-Reiche AS; Sordillo E; van Bakel H; Simon V
    Res Sq; 2021 Dec; ():. PubMed ID: 34981044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters.
    Halfmann PJ; Iida S; Iwatsuki-Horimoto K; Maemura T; Kiso M; Scheaffer SM; Darling TL; Joshi A; Loeber S; Singh G; Foster SL; Ying B; Case JB; Chong Z; Whitener B; Moliva J; Floyd K; Ujie M; Nakajima N; Ito M; Wright R; Uraki R; Warang P; Gagne M; Li R; Sakai-Tagawa Y; Liu Y; Larson D; Osorio JE; Hernandez-Ortiz JP; Henry AR; Ciuoderis K; Florek KR; Patel M; Odle A; Wong LR; Bateman AC; Wang Z; Edara VV; Chong Z; Franks J; Jeevan T; Fabrizio T; DeBeauchamp J; Kercher L; Seiler P; Gonzalez-Reiche AS; Sordillo EM; Chang LA; van Bakel H; Simon V; ; Douek DC; Sullivan NJ; Thackray LB; Ueki H; Yamayoshi S; Imai M; Perlman S; Webby RJ; Seder RA; Suthar MS; García-Sastre A; Schotsaert M; Suzuki T; Boon ACM; Diamond MS; Kawaoka Y
    Nature; 2022 Mar; 603(7902):687-692. PubMed ID: 35062015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
    Case JB; Scheaffer SM; Darling TL; Bricker TL; Adams LJ; Harastani HH; Trende R; Sanapala S; Fremont DH; Boon ACM; Diamond MS
    J Virol; 2023 Sep; 97(9):e0062823. PubMed ID: 37676002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron Variants in Mice and Hamsters.
    Case JB; Scheaffer SM; Darling TL; Bricker TL; Adams LJ; Harastani H; Trende R; Sanapala S; Fremont DH; Boon ACM; Diamond MS
    bioRxiv; 2023 May; ():. PubMed ID: 37205409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice.
    Toomer G; Burns W; Garcia L; Henry G; Biancofiori A; George A; Duffy C; Chu J; Sides M; Muñoz M; Garcia K; Nikolai-Yogerst A; Peng X; Westfall L; Baker R
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
    Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
    mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2.
    Darling TL; Ying B; Whitener B; VanBlargan LA; Bricker TL; Liang CY; Joshi A; Bamunuarachchi G; Seehra K; Schmitz AJ; Halfmann PJ; Kawaoka Y; Elbashir SM; Edwards DK; Thackray LB; Diamond MS; Boon ACM
    Med; 2022 May; 3(5):309-324.e6. PubMed ID: 35584653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.
    Akkız H
    Front Med (Lausanne); 2022; 9():849217. PubMed ID: 35669924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine.
    Hawman DW; Meade-White K; Clancy C; Archer J; Hinkley T; Leventhal SS; Rao D; Stamper A; Lewis M; Rosenke R; Krieger K; Randall S; Khandhar AP; Hao L; Hsiang TY; Greninger AL; Gale M; Berglund P; Fuller DH; Rosenke K; Feldmann H; Erasmus JH
    EBioMedicine; 2022 Sep; 83():104196. PubMed ID: 35932641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice.
    Tarrés-Freixas F; Trinité B; Pons-Grífols A; Romero-Durana M; Riveira-Muñoz E; Ávila-Nieto C; Pérez M; Garcia-Vidal E; Perez-Zsolt D; Muñoz-Basagoiti J; Raïch-Regué D; Izquierdo-Useros N; Andrés C; Antón A; Pumarola T; Blanco I; Noguera-Julián M; Guallar V; Lepore R; Valencia A; Urrea V; Vergara-Alert J; Clotet B; Ballana E; Carrillo J; Segalés J; Blanco J
    Front Microbiol; 2022; 13():840757. PubMed ID: 35602059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spike protein-independent attenuation of SARS-CoV-2 Omicron variant in laboratory mice.
    Liu S; Selvaraj P; Sangare K; Luan B; Wang TT
    Cell Rep; 2022 Sep; 40(11):111359. PubMed ID: 36075211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    Elife; 2022 Feb; 11():. PubMed ID: 35191378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape.
    Rochman ND; Faure G; Wolf YI; Freddolino PL; Zhang F; Koonin EV
    mBio; 2022 Apr; 13(2):e0013522. PubMed ID: 35289643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
    Shiwa-Sudo N; Sakai Y; Iwata-Yoshikawa N; Watanabe S; Yamada S; Kuroda Y; Yamamoto T; Shirakura M; Fujisaki S; Miyazaki K; Miura H; Nagata S; Fukushi S; Maeda K; Hasegawa H; Suzuki T; Nagata N
    J Virol; 2023 Jan; 97(1):e0136622. PubMed ID: 36633406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.
    Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK
    Front Immunol; 2022; 13():1055811. PubMed ID: 36457995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of Wuhan-like and omicron-like variants of SARS-CoV-2 in experimental animal models].
    Leneva IA; Smirnova DI; Kartashova NP; Gracheva AV; Ivanina AV; Glubokova EA; Korchevaya ER; Pancratov AA; Trunova GV; Khokhlova VA; Svitich OA; Zverev VV; Faizuloev EB
    Vopr Virusol; 2022 Nov; 67(5):439-449. PubMed ID: 36515289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice.
    Cai JP; Luo C; Wang K; Cao H; Chen LL; Zhang X; Han Y; Yin F; Zhang AJ; Chu H; Yuan S; Kok KH; To KK; Chen H; Chen Z; Jin DY; Yuen KY; Chan JF
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.